The Tumor Vaccine Group at the University of Washington is a multidisciplinary group of investigators focused on the diagnosis, prevention and treatment of cancer with novel, immune-based approaches. Involving scientists, doctors, nurses, and patients, our translational research works to bring the most innovative treatments from the bench to the bedside and to harmonize scientific study with patient care.
In the News:
- Rivkin Center - Importance of Research (November 2016)
- Polyvalent Vaccine Targeting Oncogenic Driver Pathways NCI Cancer Prevention Program (July 2016)
- 6 questions in cancer immunotherapy Hutch News (March 2016)
- A Vaccine May Aid Colon Cancer Prevention in the Future American Cancer Society (April 2015)